Literature DB >> 27167729

Spectrum of clinical manifestations in two young Turkish patients with congenital generalized lipodystrophy type 4.

Gulcin Akinci1, Haluk Topaloglu2, Baris Akinci3, Huseyin Onay4, Cem Karadeniz5, Yakup Ergul6, Tevfik Demir3, Emin Evren Ozcan7, Canan Altay8, Tahir Atik9, Abhimanyu Garg10.   

Abstract

Congenital generalized lipodystrophy type 4 is an extremely rare autosomal recessive disorder. We report our clinical experience on two unrelated Turkish patients with congenital generalized lipodystrophy type 4. A 13-year-old girl (patient-1) presented with generalized lipodystrophy and myopathy. Further tests revealed ventricular and supraventricular arrhythmias, gastrointestinal dysmotility, atlantoaxial instability, lumbosacral scoliosis, and metabolic abnormalities associated with insulin resistance. A 16-year-old girl (patient-2) with congenital generalized lipodystrophy type 4 was previously reported. Here, we report on her long term clinical follow-up. She received several course of anti-arrhythmic treatments for catecholaminergic polymorphic ventricular tachycardia and rapid atrial fibrillation. An implantable cardioverter defibrillator was also placed. A homozygous PTRF mutation, c.259C > T (p.Gln87*), was identified in patient-1. Congenital generalized lipodystrophy type 4 was caused by homozygous PTRF c.481-482insGTGA (p.Lys161Serfs*41) mutation in patient-2. Our data indicate that patients with congenital generalized lipodystrophy type 4 should be meticulously evaluated for cardiac, neuromuscular, gastrointestinal and skeletal diseases, as well as metabolic abnormalities associated with insulin resistance.
Copyright © 2016 Elsevier Masson SAS. All rights reserved.

Entities:  

Keywords:  Arrhythmia; Insulin resistance; Lipodystrophy; Myopathy; PTRF

Mesh:

Substances:

Year:  2016        PMID: 27167729     DOI: 10.1016/j.ejmg.2016.05.001

Source DB:  PubMed          Journal:  Eur J Med Genet        ISSN: 1769-7212            Impact factor:   2.708


  8 in total

Review 1.  Phenotypic and Genetic Characteristics of Lipodystrophy: Pathophysiology, Metabolic Abnormalities, and Comorbidities.

Authors:  Baris Akinci; Rasimcan Meral; Elif Arioglu Oral
Journal:  Curr Diab Rep       Date:  2018-11-08       Impact factor: 4.810

2.  [A case report of congenital generalized lipodystrophy].

Authors:  Rui Liu; Hui-Jun Tan; Jia-Jia Liu; Yuan-Zong Song
Journal:  Zhongguo Dang Dai Er Ke Za Zhi       Date:  2018-10

Review 3.  Update on Therapeutic Options in Lipodystrophy.

Authors:  Baris Akinci; Rasimcan Meral; Elif Arioglu Oral
Journal:  Curr Diab Rep       Date:  2018-10-29       Impact factor: 4.810

Review 4.  Severe insulin resistance syndromes.

Authors:  Angeliki M Angelidi; Andreas Filippaios; Christos S Mantzoros
Journal:  J Clin Invest       Date:  2021-02-15       Impact factor: 14.808

5.  Genotype-phenotype correlations of Berardinelli-Seip congenital lipodystrophy and novel candidate genes prediction.

Authors:  Meng Ren; Jingru Shi; Jinmeng Jia; Yongli Guo; Xin Ni; Tieliu Shi
Journal:  Orphanet J Rare Dis       Date:  2020-04-29       Impact factor: 4.123

Review 6.  Current Diagnosis, Treatment and Clinical Challenges in the Management of Lipodystrophy Syndromes in Children and Young People

Authors:  Samim Özen; Barış Akıncı; Elif A. Oral
Journal:  J Clin Res Pediatr Endocrinol       Date:  2019-08-22

7.  Anesthesia for patients with PTRF mutations: a case report.

Authors:  Atsuko Hirano; Tomohiko Takada; Mariko Senda; Hidemasa Takahashi; Takeo Suzuki
Journal:  JA Clin Rep       Date:  2018-01-25

8.  Unusual clinical features associated with congenital generalized lipodystrophy type 4 in a patient with a novel E211X CAVIN1 gene variant.

Authors:  Ekaterina Sorkina; Polina Makarova; Liubov Bolotskaya; Irina Ulyanova; Tatyana Chernova; Anatoly Tiulpakov
Journal:  Clin Diabetes Endocrinol       Date:  2020-05-14
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.